Comparison of a Direct and Indirect Population Pharmacodynamic Model: Application to Recombinant Human Erythropoietin in Athletes

被引:0
作者
Françoise Bressolle
Michel Audran
Raynald Gareau
Tuyet-Nga Pham
Roberto Gomeni
机构
[1] Université Montpellier I,Laboratoire de Pharmacocinétique, Faculté de Pharmacie
[2] Université Montpellier I,Département de Biophysique, Faculté de Pharmacie
[3] Université de Québec,Service d'hématologie
[4] BESTFIT,undefined
来源
Journal of Pharmacokinetics and Biopharmaceutics | 1997年 / 25卷
关键词
pharmacodynamics; indirect response; sigmoid ; model; recombinant human erythropoietin;
D O I
暂无
中图分类号
学科分类号
摘要
Basic physiologic indirect response models have been proposed to account for the pharmacodynamics of drugs that act by way of inhibition or stimulation of the production or loss of endogenous substances or mediators. In this work, these models were applied to account for the effects of recombinant human erythropoietin (rHuEpo) in man. Indeed, rHuEpo induces a delayed increase of serum soluble transferrin receptors (sTfr) and a delayed decrease in ferritin (fr) concentrations. The purpose of the present study was to compare two pharmacodynamic approaches to relate serum erythropoietin (Epo) concentrations to the effect of rHuEpo on sTfr, and fr, the “indirect effect” and the “effect compartment” models. However, due to the average lag lime of about 50 hr between the first intake of rHuEpo and the onset of the measurable effects, a delay function was incorporated into the “indirect response models” to describe the relationship between the Epo plasma concentrations and the endogenous receptors or mediators affected by the drug and responsible for the effects on sTfr and fr. There are no real differences in the descriptive features of the two models used. For these reasons, the indirect model seems more appropriate because it supplies a possible mechanistic interpretation of the physiological process.
引用
收藏
页码:263 / 275
页数:12
相关论文
共 38 条
[1]  
Berglund B.(1991)Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy males J. Int. Med. 229 125-130
[2]  
Ekblom B.(1991)Effect of erythropoietin administration on maximal aerobic power in man Scand. J. Med. Sci. Sports 1 88-93
[3]  
Ekblom B.(1992)Peptides hormones and sport: Misuse and detection Br. Med. Bull. 48 496-517
[4]  
Berglund B.(1992)The molecular mechanism of erythropoietin action Eur. J. Biochem. 210 649-663
[5]  
Kicman A. T.(1994)Biology of erythropoietin Clin. Invest. 72 S3-S10
[6]  
Cowan D. A.(1996)Erythropoietin abuse in athletes Nature 380 113-360
[7]  
Koury M. J.(1996)Recombinant human erythropoietin and pharmacodynamics parameters in athletes. Interest of blood sampling for doping control Br. J. Clin. Pharmacol. 42 355-371
[8]  
Bondurant M. C.(1979)Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to Clin. Pharmacol. Ther. 25 358-419
[9]  
Jelkman W.(1994)-tubocurarine Clin. Pharmacol. Ther. 56 406-478
[10]  
Gareau R.(1993)Physiologic indirect response models characterize diverse types of pharmacodynamic effects J. Pharmacokin. Biopharm. 21 457-4